OMC
RPRX icon

Overbrook Management Corp’s Royalty Pharma RPRX Stock Holding History

Overbrook Management Corp’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-38,208
Closed -$2.14M – 72
2026
Q2 		$2.14M Hold
38,208
– – 0.32% 38
2026
Q1 		$1.83M Sell
38,208
-5,000
-12% -$219K 0.35% 34
2025
Q4 		$1.67M Hold
43,208
– – 0.29% 34
2025
Q3 		$1.52M Sell
43,208
-5,000
-10% -$181K 0.27% 33
2025
Q2 		$1.74M Sell
48,208
-10,200
-17% -$338K 0.32% 31
2025
Q1 		$1.82M Sell
58,408
-60,000
-51% -$1.9M 0.43% 31
2024
Q4 		$3.02M Sell
118,408
-22,500
-16% -$597K 0.65% 30
2024
Q3 		$3.99M Sell
140,908
-59,504
-30% -$1.65M 0.91% 27
2024
Q2 		$5.28M Sell
200,412
-8,937
-4% -$248K 1.33% 26
2024
Q1 		$6.36M Sell
209,349
-10,328
-5% -$304K 1.71% 23
2023
Q4 		$6.17M Sell
219,677
-79,035
-26% -$2.17M 1.25% 22
2023
Q3 		$8.11M Sell
298,712
-255,005
-46% -$7.57M 1.89% 22
2023
Q2 		$17M Sell
553,717
-25,066
-4% -$849K 4.04% 10
2023
Q1 		$20.9M Sell
578,783
-30,569
-5% -$1.13M 5.46% 5
2022
Q4 		$24.1M Sell
609,352
-19,550
-3% -$816K 7% 4
2022
Q3 		$25.3M Sell
628,902
-71,169
-10% -$3.04M 7.18% 3
2022
Q2 		$29.4M Sell
700,071
-23,179
-3% -$950K 8.51% 2
2022
Q1 		$28.2M Sell
723,250
-5,875
-0.8% -$231K 6.25% 2
2021
Q4 		$29.1M Sell
729,125
-56,007
-7% -$2.18M 5.86% 3
2021
Q3 		$28.4M Buy
785,132
+28,011
+4% +$1.09M 6.16% 2
2021
Q2 		$31M Sell
757,121
-14,034
-2% -$597K 6.49% 2
2021
Q1 		$33.6M Sell
771,155
-7,356
-0.9% -$349K 7.48% 2
2020
Q4 		$39M Buy
778,511
+670,759
+623% +$28.5M 9.51% 1
2020
Q3 		$4.53M Buy
+107,752
New +$4.62M 1.05% 24

Other funds holding RPRX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
KA
Kearns & Associates Palos Verdes Estates, California $218M AUM 16.36% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Overbrook Management Corp's RPRX Position: Q3 2026 in Review

Overbrook Management Corp sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 38,208 shares — an estimated $2.14M sold.

Overbrook Management Corp first reported a position in RPRX in Q3 2020 and held it in 24 quarters. The position peaked at $39M in Q4 2020. 21 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Overbrook Management Corp reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
  • Overbrook Management Corp sold 38,208 Royalty Pharma shares in Q3 2026, an estimated $2.14M.
  • Overbrook Management Corp first reported a position in Royalty Pharma in Q3 2020 and held it in 24 quarters.
  • Overbrook Management Corp's Royalty Pharma position peaked at $39M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Overbrook Management Corp's 13F filing for Q3 2026, filed 8 Oct 2026.